Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
01 1COHANCE LIFESCIENCES LIMITED
02 1AGC Pharma Chemicals Europe, S.L.U.
03 1Glenmark Life Sciences Limited
04 1Mylan Laboratories Limited
05 1Professional Compounding Centers of America dba PCCA
06 1Societa Italiana Medicinali Scandicci S.I.M.S., SrL
07 1Tianish Laboratories Private Limited
01 4DIPYRIDAMOLE
02 3Dipyridamole
01 3India
02 1Italy
03 1U.S.A
04 2United Kingdom
Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.
NDC Package Code : 17511-122
Start Marketing Date : 2020-01-20
End Marketing Date : 2026-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 65404-005
Start Marketing Date : 1999-01-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1mg/mg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 66039-917
Start Marketing Date : 2015-03-31
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 51927-1571
Start Marketing Date : 2013-06-28
End Marketing Date : 2027-01-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 12660-0084
Start Marketing Date : 1979-02-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 84206-0029
Start Marketing Date : 2024-08-26
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 65015-782
Start Marketing Date : 2015-08-20
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
66
PharmaCompass offers a list of Dipyridamole API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dipyridamole manufacturer or Dipyridamole supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dipyridamole manufacturer or Dipyridamole supplier.
PharmaCompass also assists you with knowing the Dipyridamole API Price utilized in the formulation of products. Dipyridamole API Price is not always fixed or binding as the Dipyridamole Price is obtained through a variety of data sources. The Dipyridamole Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Antistenocardin manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Antistenocardin, including repackagers and relabelers. The FDA regulates Antistenocardin manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Antistenocardin API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Antistenocardin manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Antistenocardin supplier is an individual or a company that provides Antistenocardin active pharmaceutical ingredient (API) or Antistenocardin finished formulations upon request. The Antistenocardin suppliers may include Antistenocardin API manufacturers, exporters, distributors and traders.
click here to find a list of Antistenocardin suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Antistenocardin as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Antistenocardin API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Antistenocardin as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Antistenocardin and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Antistenocardin NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Antistenocardin suppliers with NDC on PharmaCompass.
We have 7 companies offering Antistenocardin
Get in contact with the supplier of your choice:
